CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands		Total	Previously Reported, Before Reclassification	Recapitalization	Adjusted Balance	Common Stock		Common Stock Previously Reported, Before Reclassification		Common Stock Recapitalization		Common Stock Adjusted Balance		Notes Receivables from Stockholders	Notes Receivables from Stockholders Previously Reported, Before Reclassification	Notes Receivables from Stockholders Adjusted Balance	Additional Paid-in Capital		Additional Paid-in Capital Previously Reported, Before Reclassification	[1]	Additional Paid-in Capital Recapitalization	[1]	Additional Paid-in Capital Adjusted Balance	[1]	Accumulated Deficit	Accumulated Deficit Previously Reported, Before Reclassification	Accumulated Deficit Adjusted Balance	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss Previously Reported, Before Reclassification	Accumulated Other Comprehensive Loss Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2022			2,174,429	4,471,866	6,646,295
Beginning balance at Dec. 31, 2022			$ 436,280		$ 436,280
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of convertible preferred stock to common stock (in shares)		(6,646,295)
Conversion of convertible preferred stock to common stock		$ (436,280)
Ending balance (in shares) at Dec. 31, 2023		0
Ending balance at Dec. 31, 2023		$ 0
Beginning balance (in shares) at Dec. 31, 2022	[1]							1,961,567		4,034,101		5,995,668
Beginning balance at Dec. 31, 2022			$ (604,183)		$ (604,183)			$ 0	[1]	$ 1	[1]	$ 1	[1]		$ (53,225)	$ (53,225)			$ 618,121		$ (1)		$ 618,120			$ (1,167,656)	$ (1,167,656)		$ (1,423)	$ (1,423)
Increase (Decrease) in Stockholders' Equity
Conversion of convertible preferred stock to common stock (in shares)	[1]					6,646,295
Conversion of convertible preferred stock to common stock		436,279				$ 1	[1]										$ 436,278	[1]
Conversion of pre-closing bridge notes to common stock (in shares)	[1]					2,100,000
Conversion of pre-closing bridge notes to common stock		750,000															750,000	[1]
Issuance of common stock upon Business Combination close (in shares)	[1]					200,090
Issuance of common stock upon Business Combination close		37,966															37,966	[1]
Exercise of warrants (in shares)	[1]					291,523
Exercise of warrants		4,289															4,289	[1]
Transaction costs related to the Business Combination		(17,173)															(17,173)	[1]
Recognition of derivative liability related to earnout		(548)															(548)	[1]
Assumption private placement and public warrants		(1,276)															(1,276)	[1]
Issuance of common stock for options exercised (in shares)	[1]					36,291
Issuance of common stock for options exercised		656															656	[1]
Cancellation of common stock (in shares)	[1]					(56,110)
Cancellation of common stock		(8)															(8)	[1]
Stock-based compensation		58,284															58,284	[1]
Tax withholding upon vesting of restricted stock units		(5,966)															(5,966)	[1]
Shares issued for vested restricted stock units (in shares)	[1]					280,148
Shares issued for vested restricted stock units		0
Vesting of common stock issued via notes receivable from stockholders		0												$ (3,561)			3,561	[1]
Forfeiture of shares (in shares)	[1]					(308,813)
Forfeiture of shares		2												30,487			(30,485)	[1]
Forgiveness of officer loans		988												988
Shares transferred in settlement of loans (in shares)	[1]					(149,626)
Shares transferred in settlement of loans		1												15,200			(15,199)	[1]
Net loss		(536,420)		$ 0																					$ (536,420)
Other comprehensive loss— foreign currency translation adjustment, net of tax		$ (291)																										$ (291)
Ending balance (in shares) at Dec. 31, 2023		15,035,467				15,035,467	[1]
Ending balance at Dec. 31, 2023		$ 122,600				$ 2	[1]							(10,111)			1,838,499	[1]							(1,704,076)			(1,714)
Increase (Decrease) in Stockholders' Equity
Transaction costs related to the Business Combination																	17,200
Recognition of derivative liability related to earnout		0
Assumption private placement and public warrants		0
Adjustment of transaction costs related to Business Combination		$ (2,372)															(2,372)	[1]
Issuance of common stock for options exercised (in shares)		5,212				6,814	[1]
Issuance of common stock for options exercised		$ 1,560															1,560	[1]
Cancellation of common stock (in shares)	[1]					(30,673)
Stock-based compensation		28,534															28,534	[1]
Tax withholding upon vesting of restricted stock units (in shares)						(67,235)
Tax withholding upon vesting of restricted stock units		(1,972)															(1,972)	[1]
Shares issued for vested restricted stock units (in shares)	[1]					224,422
Vesting of common stock issued via notes receivable from stockholders		(8)												(893)			885	[1]
Settlement of notes receivable from stockholders		0												1,846			(1,846)	[1]
Net loss		(206,290)																							(206,290)
Other comprehensive loss— foreign currency translation adjustment, net of tax		$ (222)																										(222)
Ending balance (in shares) at Dec. 31, 2024		15,168,795				15,168,795	[1]
Ending balance at Dec. 31, 2024		$ (58,170)				$ 2	[1]							$ (9,158)			$ 1,863,288	[1]							$ (1,910,366)			$ (1,936)

[1] Periods have been adjusted to reflect the 1-for-50 reverse stock split on August 16, 2024. See Note 1 Organization and Nature of the Business - Reverse Stock Split, for additional information.